These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.
    Author: Henriksson P, Eriksson A, Stege R, Collste L, Pousette A, von Schoultz B, Carlström K.
    Journal: Prostate; 1988; 13(3):257-61. PubMed ID: 3211807.
    Abstract:
    Thirty-eight patients with cancer of the prostate were treated with strict parenteral estrogen in the form of monthly polyestradiol phosphate injections--160 mg, 240 mg, and 320 mg--in this nonrandomized study. In contrast to studies with oral estrogens, there have been no cardiovascular complications at a mean follow-up of 12.9 +/- 0.7 months (SEM). Twenty-nine of the 38 patients (76%) have responded to therapy.
    [Abstract] [Full Text] [Related] [New Search]